Fact CheckerSign in

NCT07684430Completed

Effect of a Digital Health Education Program on Quality of Life in Women With Polycystic Ovary Syndrome

Effect of a Digital Health Education Program on Quality of Life in Women With Polycystic Ovary Syndrome: Randomized Controlled Trial

Source: ClinicalTrials.gov · Last updated 6 Jul 2026

Brief summary (registry, in English)

This single-blind randomized controlled trial evaluated the effectiveness of a digital health education program delivered through WhatsApp in improving the quality of life of women with polycystic ovary syndrome (PCOS). Seventy women diagnosed with PCOS were enrolled from selected gynecology clinics in Imo State, Nigeria, and allocated to either an intervention group or a routine care control group. The intervention consisted of a four-week digital education program including 30 evidence-based educational messages. Quality of life was measured using the Polycystic Ovary Syndrome Quality of Life Questionnaire (PCOSQ) at baseline and one month after completion of the intervention.

Status (registry)
Completed
Study type
Interventional
Enrollment
70 (actual)
First submitted
29 Jun 2026
Start date
25 Apr 2026
Primary completion date
24 Jun 2026
Lead sponsor
Near East University, Turkey
NCT number
NCT07684430

What you commit to

  • Study type: Interventional
  • Participants enrolled: 70
  • From 25 Apr 2026 to the primary completion date, 24 Jun 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Failure to complete either the pre-test or post-test assessments

Other

  • Withdrawal of consent at any stage of the study
  • Incomplete participation in the educational intervention program

Who the study is looking for

  • Women diagnosed with polycystic ovary syndrome
  • Women aged 18-45 years
  • Women attending the selected women's health wards and gynecology clinics during the study period
  • Willingness to participate and provide written informed consent

Age in the registry: 18 years to 45 years · Sex: Female · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Pouran Varvani Farahani
Coordinator of this site? Confirm its status
NicosiaCyprusUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.